Stocks Hitting 52-Week Highs

Sarepta Therapeutics

shares jumped 106.80% to create a new 52-week high of $31.00. Sarepta Therapeutics reported that treatment with its eteplirsen met its primary endpoint in a Phase IIb extension trial in Duchenne muscular dystrophy patients. SurModics

shares gained 0.42% to touch a new 52-week high of $21.48. SurModics shares have surged 133.77% over the past 52 weeks, while the S&P 500 index has gained 28.63% in the same period. Rockville Financial

shares rose 1.02% to create a new 52-week high of $12.83. Rockville Financial is estimated to report its Q3 results on October 25. Ocwen Financial

shares gained 15.16% to create a new 52-week high of $33.35. Ocwen Financial announced its plans to acquire Homeward Residential Holdings from WL Ross & Co LLC.